NewGenIvf Group Ltd is a SG-based company operating in Health Care Providers & Services industry. The company employs 76 full-time employees The company went IPO on 2022-02-15. NewGenIvf Group Limited is a comprehensive fertility services provider in Asia, helping couples and individuals obtain access to fertility treatments. The firm offers services, such as Mitochondrial Replacement Therapy (MRT) In Reproductive, Intrauterine Insemination (IUI), MRT techniques, In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI), semen analysis, testicular/epididymal sperm aspiration or extraction/percutaneous epididymal sperm aspiration, embryo transfer, chromosome screening, and egg freezing. The Company’s clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. The Company’s subsidiary is NewGenIvf Limited.
Follow-Up Questions
¿Quién es el CEO de NewGenIvf Group Ltd?
Mr. Claudius Tsang es el Chairman of the Board de NewGenIvf Group Ltd, se unió a la empresa desde 2021.
¿Qué tal es el rendimiento del precio de la acción NIVF?
El precio actual de NIVF es de $1.2, ha decreased un 1.91% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de NewGenIvf Group Ltd?
NewGenIvf Group Ltd pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de NewGenIvf Group Ltd?
La capitalización bursátil actual de NewGenIvf Group Ltd es $2.2M
